A team of Houston college students laced in the top 10 percent of 7,800 students at the National Cyber League competition. Photo courtesy of HCC

A team from Houston Community College had a strong showing earlier this month at the spring National Cyber League competition.

A team of HCC students placed in the top 10 percent of finishers, according to a statement from the college. More than 7,800 students from 450 universities and colleges across the U.S.competed in the semi-annual competition that tests participants’ skills in identifying hackers from forensic data, penetration testing, auditing vulnerable websites and recovering from ransomware attacks through a series of games.

“Our goal is to empower our students with the knowledge and tools they need to succeed as leaders in information technology, including the fast growing and in-demand areas of cyber security and artificial intelligence,” Dr. Madeline Burillo-Hopkins, president of HCC Southwest College and vice chancellor of workforce, says in a statement. “Again and again, we find that our students perform exceptionally well when compared to those from colleges and universities across the nation.”

Hira Ali, a participant and mother of two who served as vice president of the HCC Cyber Security Club before graduating this year, says the experience pushed her and her teammates to expand their knowledge outside of the classroom.

“It was a great experience for us,” she says in a statement. “It presented us, as teammates, with the opportunity to venture beyond our comfort zones and delve into unfamiliar concepts."

Ali added that she ate almost nothing and slept little for a week because she and her team were "totally immersed in the competition.” She plans to enroll in a four-year online degree program through Dakota State University.

According to Samir Saber, dean of HCC’s Digital, and Information Technology Center of Excellence, there are about 57,878 cyber jobs in Texas alone. HCC also shared that the median salary for security analysts in the Houston area is about $101,000, according to Lightcast, a labor market data analysis firm.

Earlier this month, HCC also announced that it would be rolling out a new innovation 60-hour degree program in the fall. The Smart Building Technology program will train students on the installation of low-voltage controls. Students will receive an Associate of Applied Science degree after completing the program, which is part of HCC Central’s Electrical Technology program in the Architectural Design and Construction Center of Excellence (COE).

In late 2022, HCC and partners also received a $1.8 million grant from JP Morgan Chase to launch a new certificate program to help residents who come from some of Houston’s most underserved and under-resourced neighborhoods find career opportunities in the clean energy, disaster response, utilities, trades and manufacturing fields. Partnering employers included The City of Houston, Harris County and TRIO Electric.

Houston Community College will have a new program this fall focused on smart building tech. Photo via HCC.edu

Houston college to launch new smart building degree-program in the fall

coming soon

Houston Community College will launch a new 60-hour Smart Building Technology program this fall, the college announced last week.

The program will train students on the installation of low-voltage controls, such as audio/visual systems, energy management, lighting controls, security cameras, burglar and fire alarm systems, retail and grocery store automation, medical automation and more, according to HCC. Students will receive an Associate of Applied Science degree after completing the program.

“This program is both cutting edge and down to earth,” Matt Adams, instructor and program coordinator for HCC’s Electrical Technology program, said in a statement.

"A lot of new technology is coming into this industry, but a lot of the technology is the same as it has been for the last five to 10 years," he went on to add. "What is new is the integration of it all, making it all work together, to make people’s lives better.”

The Smart Building Technology program will be part of HCC Central’s Electrical Technology program in the Architectural Design and Construction Center of Excellence (COE). According to the college, it's one of the first programs of its kind.

Adams says that the earning potential in this line of work starts at around $50,000 a year, with the potential to earn double that with additional learning and training.

In late 2022, HCC and partners also received a $1.8 million grant from JP Morgan Chase to launch a new certificate program to help residents who come from some of Houston’s most underserved and under-resourced neighborhoods find career opportunities in the clean energy, disaster response, utilities, trades and manufacturing fields. Partnering employers included The City of Houston, Harris County and TRIO Electric.

Meanwhile, Houston Methodist and Texas A&M University graduated the inaugural class from its School of Engineering Medicine earlier this month.

Graphic courtesy of HCC

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Texas tops ranking of best state for investors in new report

by the numbers

Texas ranks third on a new list of the best states for investors and startups.

Investment platform BrokerChooser weighed five factors to come up with its ranking:

  • 2024 Google search volume for terms related to investing
  • Number of investors
  • Number of businesses receiving investments in 2024
  • Total amount of capital invested in businesses in 2024
  • Percentage change in amount of investment from 2019 to 2024

Based on those figures, provided mostly by Crunchbase, Texas sits at No. 3 on the list, behind No. 1 California and No. 2 New York.

Especially noteworthy for Texas is its investment total for 2024: more than $164.5 billion. From 2019 to 2024, the state saw a 440 percent jump in business investments, according to BrokerChooser. The same percentages are 204 percent for California and 396 percent for New York.

“There is definitely development and diversification in the American investment landscape, with impressive growth in areas that used to fly under the radar,” says Adam Nasli, head analyst at BrokerChooser.

According to Crunchbase, funding for Texas startups is off to a strong start in 2025. In the first three months of this year, venture capital investors poured nearly $2.9 billion into Lone Star State companies, Crunchbase data shows. Crunchbase attributes that healthy dollar amount to “enthusiasm around cybersecurity, defense tech, robotics, and de-extincting mammoths.”

During the first quarter of this year, roughly two-thirds of VC funding in Texas went to just five companies, says Crunchbase. Those companies are Austin-based Apptronik, Austin-based Colossal Biosciences, Dallas-based Island, Austin-based NinjaOne, and Austin-based Saronic.

Autonomous truck company rolls out driverless Houston-Dallas route

up and running

Houston is helping drive the evolution of self-driving freight trucks.

In October, Aurora opened a more than 90,000-square-foot terminal at a Fallbrook Drive logistics hub in northwest Houston to support the launch of its first “lane” for driverless trucks—a Houston-to-Dallas route on the Interstate 45 corridor. Aurora opened its Dallas-area terminal in April and the company began regular driverless customer deliveries between the two Texas cities on April 27.

Close to half of all truck freight in Texas moves along I-45 between Houston and Dallas.

“Now, we are the first company to successfully and safely operate a commercial driverless trucking service on public roads. Riding in the back seat for our inaugural trip was an honor of a lifetime – the Aurora Driver performed perfectly and it’s a moment I’ll never forget,” Chris Urmson, CEO and co-founder of Pittsburgh-based Aurora, said in a news release.

Aurora produces software that controls autonomous vehicles and is known for its flagship product, the Aurora Driver. The software is installed in Volvo and Paccar trucks, the latter of which includes brands like Kenworth and Peterbilt.

Aurora previously hauled more than 75 loads per week under the supervision of vehicle operators from Houston to Dallas and Fort Worth to El Paso for customers in its pilot project, including FedEx, Uber Freight and Werner. To date, it has completed over 1,200 miles without a driver.

The company launched its new Houston to Dallas route with customers Uber Freight and Hirschbach Motor Lines, which ran supervised commercial pilots with Aurora.

“Transforming an old school industry like trucking is never easy, but we can’t ignore the safety and efficiency benefits this technology can deliver. Autonomous trucks aren’t just going to help grow our business – they’re also going to give our drivers better lives by handling the lengthier and less desirable routes,” Richard Stocking, CEO of Hirschbach Motor Lines, added in the statement.

The company plans to expand its service to El Paso and Phoenix by the end of 2025.

“These new, autonomous semis on the I-45 corridor will efficiently move products, create jobs, and help make our roadways safer,” Gov. Greg Abbott added in the release. “Texas offers businesses the freedom to succeed, and the Aurora Driver will further spur economic growth and job creation in Texas. Together through innovation, we will build a stronger, more prosperous Texas for generations.”

In July, Aurora said it raised $820 million in capital to fuel its growth—growth that’s being accompanied by scrutiny.

In light of recent controversies surrounding self-driving vehicles, the International Brotherhood of Teamsters, whose union members include over-the-road truckers, recently sent a letter to Lt. Gov. Dan Patrick calling for a ban on autonomous vehicles in Texas.

“The Teamsters believe that a human operator is needed in every vehicle—and that goes beyond partisan politics,” the letter states. “State legislators have a solemn duty in this matter to keep dangerous autonomous vehicles off our streets and keep Texans safe. Autonomous vehicles are not ready for prime time, and we urge you to act before someone in our community gets killed.”

Houston cell therapy company launches second-phase clinical trial

fighting cancer

A Houston cell therapy company has dosed its first patient in a Phase 2 clinical trial. March Biosciences is testing the efficacy of MB-105, a CD5-targeted CAR-T cell therapy for patients with relapsed or refractory CD5-positive T-cell lymphoma.

Last year, InnovationMap reported that March Biosciences had closed its series A with a $28.4 million raise. Now, the company, co-founded by Sarah Hein, Max Mamonkin and Malcolm Brenner, is ready to enroll a total of 46 patients in its study of people with difficult-to-treat cancer.

The trial will be conducted at cancer centers around the United States, but the first dose took place locally, at The University of Texas MD Anderson Cancer Center. Dr. Swaminathan P. Iyer, a professor in the department of lymphoma/myeloma at MD Anderson, is leading the trial.

“This represents a significant milestone in advancing MB-105 as a potential treatment option for patients with T-cell lymphoma who currently face extremely limited therapeutic choices,” Hein, who serves as CEO, says. “CAR-T therapies have revolutionized the treatment of B-cell lymphomas and leukemias but have not successfully addressed the rarer T-cell lymphomas and leukemias. We are optimistic that this larger trial will further validate MB-105's potential to address the critical unmet needs of these patients and look forward to reporting our first clinical readouts.”

The Phase 1 trial showed promise for MB-105 in terms of both safety and efficacy. That means that potentially concerning side effects, including neurological events and cytokine release above grade 3, were not observed. Those results were published last year, noting lasting remissions.

In January 2025, MB-105 won an orphan drug designation from the FDA. That results in seven years of market exclusivity if the drug is approved, as well as development incentives along the way.

The trial is enrolling its single-arm, two-stage study on ClinicalTrials.gov. For patients with stubborn blood cancers, the drug is providing new hope.